Are you up-to-date on what the latest advice is on getting a COVID-19 vaccine or booster? If you’re not, you are not alone. Public awareness of a new booster is “modest,” according to the results of a non-profit organization’s survey called the KFF COVID-19 Vaccine Monitor, published September 30th. Their survey found that fully half of...
Read More
Are you ever skeptical when you see drug claims? One of my first questions when I read about a new drug or a statistic of some kind is: How do they know that? When I read about two new weight loss drugs presented at the European Association for the Study of Diabetes (EASD) in Stockholm, Sweden (19-23 Sept), my antennae went up. Here’s the story. Drug...
Read More
While smoking remains the primary cause of lung cancer, 10 – 20% of people who develop non-small cell lung cancer (NSCLC) never smoked. NSCLC in non-smokers happens more often to women, and at an earlier age, than it does in smokers. What would cause cancer to develop without smoking? [1] One theory is that environmental factors,...
Read More
KRAS, one gene present in some cancers, was considered “undruggable” for years.[1] Mutated KRAS is an important target for patients with non-small cell lung cancer (NSCLC) because it’s present in 20-25% of cases.[2] Finally, one drug, sotorasib (Lumakras), is approved to treat one mutant form of KRAS gene, KRAS G12C.[3] This mutation appears in...
Read More
Recent studies contribute to the evidence that there are benefits to drinking coffee. Here’s the current scientific thinking on the subject. Recently published research: One study, published in 2022, examines data from a 16,000 person study called Atherosclerosis Risk in Communities (ARIC). ARIC’s study goal is to see if there’s any...
Read More
